UPDATE: Truist Securities Upgrades Editas Medicine (EDIT) to Buy

August 9, 2021 6:17 AM EDT Send to a Friend
(Updated - August 9, 2021 7:16 AM EDT)

Truist Securities analyst Joon Lee upgraded Editas Medicine (NASDAQ: EDIT) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login